ES382000A1 - A procedure for the preparation of pharmaceutical compositions of antidepressor properties. (Machine-translation by Google Translate, not legally binding) - Google Patents

A procedure for the preparation of pharmaceutical compositions of antidepressor properties. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES382000A1
ES382000A1 ES382000A ES382000A ES382000A1 ES 382000 A1 ES382000 A1 ES 382000A1 ES 382000 A ES382000 A ES 382000A ES 382000 A ES382000 A ES 382000A ES 382000 A1 ES382000 A1 ES 382000A1
Authority
ES
Spain
Prior art keywords
translation
preparation
pharmaceutical compositions
machine
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES382000A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES382000A1 publication Critical patent/ES382000A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for the preparation of pharmaceutical compositions with antidepressant properties, suitable for the treatment of various types of non-psychotic depression, such as simple, acute, chronic and involuntary psychoneurotic depression, characterized in that it comprises mixing 7-chloro-2,3-dihydro- 1-methyl-5-phenyl-1H-1,4-benzodiazepine, or a pharmaceutically acceptable acid addition salt thereof, with 5- (3-dimethylaminopropyliden) -dibenzo [a, d] [1,4] cycloheptadiene, or a pharmaceutically acceptable acid addition salt thereof, and, if necessary, add pharmaceutically acceptable carrier materials and/or excipients. (Machine-translation by Google Translate, not legally binding)
ES382000A 1969-07-21 1970-07-20 A procedure for the preparation of pharmaceutical compositions of antidepressor properties. (Machine-translation by Google Translate, not legally binding) Expired ES382000A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1109969 1969-07-21

Publications (1)

Publication Number Publication Date
ES382000A1 true ES382000A1 (en) 1974-12-16

Family

ID=4370039

Family Applications (1)

Application Number Title Priority Date Filing Date
ES382000A Expired ES382000A1 (en) 1969-07-21 1970-07-20 A procedure for the preparation of pharmaceutical compositions of antidepressor properties. (Machine-translation by Google Translate, not legally binding)

Country Status (12)

Country Link
AT (1) AT297217B (en)
BE (1) BE753598A (en)
CA (1) CA946287A (en)
DE (1) DE2033702A1 (en)
ES (1) ES382000A1 (en)
FR (1) FR2059536B1 (en)
GB (1) GB1305738A (en)
IE (1) IE34397B1 (en)
IL (1) IL34903A0 (en)
MY (1) MY7500273A (en)
NL (1) NL164745C (en)
ZA (1) ZA704677B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136835C (en) * 1965-12-03

Also Published As

Publication number Publication date
NL7009462A (en) 1971-01-25
GB1305738A (en) 1973-02-07
DE2033702A1 (en) 1971-02-04
FR2059536A1 (en) 1971-06-04
IE34397B1 (en) 1975-04-30
ZA704677B (en) 1971-05-27
AT297217B (en) 1972-03-10
IL34903A0 (en) 1970-09-17
CA946287A (en) 1974-04-30
FR2059536B1 (en) 1973-08-10
BE753598A (en) 1971-01-18
MY7500273A (en) 1975-12-31
NL164745C (en) 1981-02-16
NL164745B (en) 1980-09-15
IE34397L (en) 1971-01-21

Similar Documents

Publication Publication Date Title
KR930016091A (en) Method for preparing a solid dispersion of an almost water-insoluble drug
MD960330A (en) Nonpeptidyl compounds, pharmaceutical composition on base thereof, treatment process
DE19875032I2 (en) Mometasone furoate monohydrate, process for its preparation and pharmaceutical compositions containing the same
OA09458A (en) Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof.
ATE146674T1 (en) PHARMACEUTICAL COMPOSITION FOR RECTAL ADMINISTRATION OF ACTIVE INGREDIENTS HAVING TOPICAL MEDICAL EFFECTS AT THE COLON INTESTINAL LEVEL
SE8504945D0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ANTHRACYCLINE GLYCOSIDES
JPS5231839A (en) Drug for cosmetics and permanent wave in combination
PT101444A (en) SYNERGIZING ASSOCIATION WITH ANTAGONIST EFFECT OF RECEPTORS NK1 AND NK2, USE OF ANTAGONIST ACTIVITY OF NK1 AND NK2 RECEPTORS IN THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THE REFERENCE ASSOCIATION
DE3887068D1 (en) 2,2-Dimethylchromene derivatives, process for their preparation and pharmaceutical compositions containing them.
EP0230264A3 (en) Pharmaceutical composition for nasal application, process for its preparation and its use
GB1403900A (en) Pharmaceutical composition
MX9203361A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING GALIUM CHLORIDE.
ES382000A1 (en) A procedure for the preparation of pharmaceutical compositions of antidepressor properties. (Machine-translation by Google Translate, not legally binding)
SE9403389D0 (en) Pharmaceutical composition containing derivatives of sex hormones
MY108692A (en) Topical composition
ES8200678A1 (en) Dibenzazepine derivatives, their production and pharmaceutical compositions containing them.
CO4750645A1 (en) PREPARATION METHOD OF GRANULES INCORPORATING A MEDICINE FOR PHARMACEUTICAL USE
ATE22282T1 (en) PENTACYCLOUNDECAN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
NL7711777A (en) BIOLOGICALLY ACTIVE TRICYCLIC COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN THOSE COMPOUNDS AS THE ACTIVE INGREDIENT.
ATE82128T1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER.
ES287586A1 (en) A procedure for the preparation of a therapeutic composition (Machine-translation by Google Translate, not legally binding)
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
ES321672A1 (en) Procedure for the manufacture of a pharmaceutical composition for the prevention and treatment of hemorrhage, pain, shock and the answers trauma consequences. (Machine-translation by Google Translate, not legally binding)
ES334076A1 (en) A procedure for the preparation of a therapeutic composition. (Machine-translation by Google Translate, not legally binding)
GB1117200A (en) A process for the manufacture of benzdiaz[1,4]epines